Clinical trials: Enteral Nutrition Feeding
Enteral Feeding
Tolerance of a Calorically Dense Enteral Nutrition Formula
This prospective observational study seeks to demonstrate the ability to meet nutritional needs of a calorically dense enteral formula in critically ill patients.
- Trial name
- NCT02806427
- Testing
- Enteral Formula
- Where
- United States
- Volunteers
- 29 people
- Sponsor
- Société des Produits Nestlé (SPN)
Prematurity
Dietary Protein in the Very-low-birth-weight Infant
In this randomized study The investigators aim to compare the growth of very-low-birth-weight (VLBW) infants fed either a high protein or a standard protein preterm infant formula.
- Trial name
- NCT01208493
- Testing
- preterm infant formula with high protein levels, preterm standard infant formula
- Where
- 4 sites in United States, Belgium and 2 more
- Volunteers
- 70 people, healthy volunteers welcome
- Sponsor
- Société des Produits Nestlé (SPN)
Critical Illness, Obesity
Feeding Trial in the Obese Critical Care Population
This study will assess enteral feeding in an obese critically ill population with a higher protein whey based peptide formula.
- Trial name
- NCT01357200
- Testing
- enteral formula
- Where
- 2 sites in United States
- Volunteers
- 26 people
- Sponsor
- Société des Produits Nestlé (SPN)
Enteral Feeding Intolerance, Tube Feeding
Review of Enteral Formulas in Children
Retrospective review of nutrition enteral formula data documented in medical records.
- Conditions
- Enteral Feeding Intolerance, Tube Feeding, Nutrition Disorder, Child
- Trial name
- NCT04247269
- Testing
- Enteral Tube Feeding
- Where
- United States
- Sponsor
- Société des Produits Nestlé (SPN)
Critically Ill Children
Improvement Project To Optimizing Nutrition With Higher Protein and Calorie Pediatric Tube Feeding
This quality improvement project will include a practice change based on national guidelines for the nutritional management of PICU patients.
- Trial name
- NCT03017664
- Testing
- Peptide-based enteral formula, Retrospective review of enteral tube feeding formula
- Where
- 2 sites in United States
- Volunteers
- 28 people
- Sponsor
- Société des Produits Nestlé (SPN)
Cancer, Neurological Disorder
Bolus Pouch Feed Study
The primary aim of this study is to evaluate the impact of introducing a new enteral tube feed on health and feeding related quality of life.
- Conditions
- Cancer, Neurological Disorder, Gastrointestinal Dysfunction, Oral Complication
- Trial name
- NCT05822557
- Testing
- Bolus Pouch Feed
- Where
- 15 sites in United Kingdom
- Volunteers
- 30 people
- Sponsor
- Nutricia UK Ltd
Gastroparesis
Evaluation of Single Doses of GSK962040 in Critically Ill Patients With Enteral Feed Intolerance
The aims of MOT112571 are to assess the pharmacodynamic effects, safety, tolerability, pharmacokinetics, and potential therapeutic benefit of single doses of GSK962040 in critically ill patients with delayed gastric emptying and…
- Trial name
- NCT01039805
- Testing
- GSK962040 (50 mg), GSK962040 (75 mg)
- Where
- Australia
- Volunteers
- 34 people
- Sponsor
- GlaxoSmithKline
Colonoscopy
Evaluating the Effectiveness of Colon Preparation for Endoscopy Using Specialized Clinical Nutrition
This study is an open, prospective, comparative diagnostic studies aimed at improving the colonoscopy results, by optimizing the way of preparation for endoscopy
- Trial name
- NCT02714296
- Testing
- Nutridrink 200 ml, Nutridrink compact protein
- Where
- Russia
- Volunteers
- 150 people
- Sponsor
- Nutricia Advanced
Infant, Premature, Infant, Newborn
A Study of Cisapride in Premature Infants With Feeding Problems
The purpose of this study is to evaluate the effectiveness of Cisapride in improving feeding problems in premature newborn infants.
- Trial name
- NCT01281566
- Testing
- Cisapride
- Volunteers
- 8 people
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Critical Illness, Enteral Nutrition
Optimizing Enteral Nutrition Regimen for Critically Ill Patients
Clinical Trial The goal of this clinical trial is to learn whether different enteral feeding cycles (18-hour, 20-hour, or standard 24-hour continuous feeding) improve outcomes for critically ill ICU patients who need tube…
- Conditions
- Critical Illness, Enteral Nutrition, Ventilator Associated Pneumonia, Hyperglycemia
- Trial name
- NCT07270939
- Testing
- 20-Hour Cycled Enteral Nutrition with a 4-Hour Fasting Window, 18-Hour Cycled Enteral Nutrition with a 6-Hour Fasting Window
- Volunteers
- 150 people
- Sponsor
- Hamad Medical Corporation
Enteral Feeding Intolerance
Retrospective Tube Feeding Tolerance in Adults With Intolerance After Switch to a Peptide-Based Formula
A retrospective chart review to assess feeding tolerance in adults who had been switched from an intact protein formula to a peptide-based formula due to feeding intolerance in a complex continuing care facility.
- Trial name
- RAP (NCT03048409)
- Testing
- Enteral Formula
- Where
- Canada
- Volunteers
- 10 people
- Sponsor
- Société des Produits Nestlé (SPN)
Enteral Feeding Intolerance
A Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of a Single Dose of Intravenous TD-8954 Compared With Metoclopramide in Critically Ill Patients With Enteral Feeding Intolerance
This study is being conducted to evaluate the safety, tolerability and early efficacy of IV TD 8954 compared to metoclopramide in critically ill subjects, aged 18 to 85 years, who are admitted to the intensive care require…
- Trial name
- NCT01953081
- Testing
- TD-8954, Metoclopramide
- Where
- Australia
- Volunteers
- 13 people
- Sponsor
- Takeda
Enteral Feeding Intolerance (EFI)
Efficacy, Safety, and Pharmacokinetics (PK) Study of Ulimorelin in Patients With Enteral Feeding Intolerance (EFI): The PROMOTE Trial
The purpose of this study is to evaluate the effect Ulimorelin in patients with enteral feeding intolerance.
- Trial name
- PROMOTE (NCT02784392)
- Testing
- Ulimorelin, Metoclopramide
- Where
- 5 sites in United States, Netherlands and 1 more
- Volunteers
- 120 people
- Sponsor
- Lyric Pharmaceuticals
Gastrointestinal Tolerance
TolerUp Enteral Feeding Protocol
This prospective, observational, multi-center study will follow children with cerebral palsy who decided to switch to an enteral product that contains partially hydrolyzed protein and medium chain triglycerides as a result of…
- Trial name
- NCT03648255
- Where
- 19 sites in Turkey (Türkiye)
- Volunteers
- 133 people
- Sponsor
- Abbott Nutrition
Feeding Tube, Dysphagia
Safety and Usability Evaluation of the Fidmi Low-Profile Enteral Feeding Device
A First In Human Usability Open Label trial will be performed using the Fidmi Feeding device on 20 adult patients with a need for enteral feeding.
- Trial name
- Fidmi (NCT03007511)
- Testing
- Fidmi enhanced enteral feeding device
- Where
- 2 sites in Israel
- Volunteers
- 20 people
- Sponsor
- Fidmi Medical
Cystic Fibrosis
Absorption and Safety With Sustained Use of RELiZORB Evaluation (ASSURE) Study
Protocol 0000498: Multicenter, open label study to evaluate the effect of sustained RELiZORB (immobilized lipase) cartridge use during enteral feeding on fat absorption, as well as safety and tolerability of sustained RELiZORB…
- Trial name
- ASSURE (NCT02750501)
- Testing
- RELiZORB (immobilized lipase) cartridge, Impact Peptide 1.5
- Where
- 10 sites in United States
- Volunteers
- 49 people
- Sponsor
- Alcresta Therapeutics, Inc.
Enteral Nutrition
Feasibility Study to Evaluate Safety of ENvizion Medical™ ENVUE™ System
This is a single center, non-randomized feasibility clinical evaluation that is designed to affirm the safety of the ENVUE™ System guidance during the placement of the ENvizion Medical™ enteral feeding tubes.
- Trial name
- NCT03505593
- Testing
- ENVUE System
- Where
- United States
- Volunteers
- 48 people
- Sponsor
- Envizion Medical Ltd.
Exocrine Pancreatic Insufficiency
Safety, Tolerability and Fat Absorption Using Enteral Feeding In-line Enzyme Cartridge (Relizorb)
Protocol ALCT-0000497 is a multicenter safety, tolerability and fat absorption study that anticipates enrolling 35 male and female subjects (pediatric and adult) with cystic fibrosis.
- Trial name
- NCT02598128
- Testing
- RELiZORB
- Where
- 11 sites in United States
- Volunteers
- 34 people
- Sponsor
- Alcresta Therapeutics, Inc.
Developmental Disabilities, Feeding Disorder
Tube Feeding Tolerance After Switch to Peptide Based Formula in Children With Developmental Delay
A retrospective chart review to assess feeding tolerance in children who had been switched from an intact protein formula to a Peptide based formula due to feeding intolerance in a pediatric facility for the developmentally…
- Trial name
- NCT02912065
- Where
- United States
- Volunteers
- 13 people
- Sponsor
- Société des Produits Nestlé (SPN)
Jejunostomy; Complications, Enteral and Supplement Feeds Adverse Reaction
Clinical Pilot Study of the Percutaneous Ultrasound Jejunostomy Procedure
The purpose of this study is to evaluate the feasibility and performance of the Percutaneous Ultrasound Jejunostomy (PUJ) procedure that utilizes a novel device (PUMA-J System) in conjunction with widely available ultrasound…
- Conditions
- Jejunostomy; Complications, Enteral and Supplement Feeds Adverse Reaction, Safety Issues
- Trial name
- NCT06095804
- Testing
- Percutaneous Ultrasound Jejunostomy
- Where
- United States
- Volunteers
- 10 people
- Sponsor
- CoapTech